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higher eukaryotes. Mutations in
ATP2C1, which encodes a human
homolog of Pmr1, result in an auto-
somal dominant skin disorder known
as Hailey-Hailey disease, character-
ized by loss of adhesion between
epidermal keratinocytes. These cells
display abnormal actin dynamics
and reduced intracellular ATP con-
centrations, which may potentially
be explained by defects in TOR sig-
naling or by changes in secretory
trafficking or Ca2+ signaling. Further
research is required to sort out the
possibilities.
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Essential nutrients enter the body through a variety of specific transporter molecules expressed in
the intestinal epithelium. A recent paper by Qiu et al. (2006) elegantly demonstrates that one of these
transporters, previously thought to carry heme, is in fact an important folate transporter.Most essential nutrients cannot diffuse
freely through biological membranes.
Instead, they enter cells through spe-
cialized transporter molecules, typi-
cally multipass transmembrane pro-
teins with exquisite specificity for their
substrates. To date, over 300 solute
carrier (SLC) transporters have been
identified based on their structural
characteristics, but definitive physio-
logical functions have been assigned
to only a fraction of them. Recently,
Shayeghi and colleagues (2005) pre-
sented evidence that a novel trans-
porter, SLC46A1, transfers dietary
heme from the intestinal lumen into
absorptive enterocytes. They identi-
fied SLC46A1 in a subtractive screen
for intestinal molecules induced in
anemic, hypoxic mice carrying a spon-
taneous mutation in the serum iron
carrier transferrin. Overexpression ofSLC46A1 in cellular assays was asso-
ciated with heme transport activity,
and the endogenous intestinal protein
relocated from the cytoplasm to the
plasma membrane in response to iron
deficiency. Based on their results,
Shayeghi et al. named this molecule
heme carrier protein 1 (HCP1).
In a recent issue of Cell, Qiu et al.
(2006) report a very different function
for SLC46A1. Using a data mining
approach based on weak homology
to the facilitative reduced folate car-
rier, they identified a series of candi-
dates for a previously characterized
yet elusive high-affinity, pH-depen-
dent folate transporter activity (Wang
et al., 2004). Of the candidate mole-
cules, only SLC46A1 showed mark-
edly diminished expression in a HeLa
cell subline selected for the loss of
high-affinity folate transport activity.Cell MetabolisWhen expressed in Xenopus oocytes
or human hepatoma cells, SLC46A1
conferred a proton-dependent folate
transport activity with substrate speci-
ficity that matched the previously
described activity.
Considering its folate transport capa-
bility, SLC46A1 now appears to be
a poor heme transporter at best. The
Km at pH 6.5 for 5-methyltetrahydro-
folate was measured at 0.8 mM (Qiu
et al., 2006), whereas the Km at neutral
pH for hemin (oxidized heme) was pre-
viously reported to be 125 mM (Shaye-
ghi et al., 2005). Any residual uncer-
tainty about the physiological role of
SLC46A1 was dispelled by the finding
that a family with hereditary folate mal-
absorption carries a loss-of-function
splicingmutation in the SLC46A1 gene
(Qiu et al., 2006). The affected children
required high doses of supplementalm 5, January 2007 ª2007 Elsevier Inc. 5
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Previewsfolate to thrive but had no
apparent defect in iron
metabolism. Based on these
converging linesof evidence,
Qiu and colleagues have
proposed thatSLC46A1now
be called proton-coupled
folate transporter (PCFT).
There are still some open
questions. First, is there
a missing heme transporter
on the apical surface of the
intestine, or might heme
iron enter absorptive cells
through a different route?
It is possible that heme
attaches to a cell-surface
receptor to be taken up by
receptor-mediated endocy-
tosis. If so, the enzymatic
breakdown of heme could
liberate iron within an endo-
some, allowing it to traverse
the cell via pathways used
for nonheme iron transport.
Second, why should PCFT,
a folate transporter, relocal-
ize to the plasma mem-
brane in response to iron
deficiency, as previously
reported (Shayeghi et al.,2005)? Why should its mRNA be in-
duced in response to hypoxia? Folate,
like iron, is essential for normal eryth-
ropoiesis, raising the intriguing possi-
bility that regulatory mechanisms exist
that coordinate the intestinal absorp-
tion of multiple essential nutrients in
response to increased or ineffective
erythropoietic activity.
Folates are derivatives of folic acid
(vitaminB9), anessential nutrient found
in a wide variety of foods. They serve
as carbon donors in several key meta-
bolic pathways. Folate transport bears
several striking similarities to transport
of iron, another essential nutrient. Both
nutrients are effectively scavenged
from a deficient mother by the devel-6 Cell Metabolism 5, January 2Figure 1. Folate Uptake Strategies
Cells use multiple strategies to assimilate folate.
(A)GPI-linked folate receptors on the cell surface bind folate anddeliver
it to an endosomal compartment through receptor-mediated endo-
cytosis pathways that are not fully understood.
(B) Reduced folates can enter the cell through a facilitative carrier
(SLC19A1), which exhibits features of an anion exchanger.
(C) The proton-coupled folate transporter (PCFT) was recently identi-
fied as SLC46A1 (Qiu et al., 2006). It is necessary for normal intestinal
absorption of dietary folate. The possibility that SLC46A1 may also
act as an endosomal transporter, analogous to the iron transporter
DMT1, has not yet been explored.007 ª200oping fetus. Both are highly concen-
trated in erythroid cells, and failure to
procure them results in anemia. Similar
to the high-affinity iron transporter
DMT1 (SLC11A2), PCFT is expressed
on the apical surface of the proximal
small intestine where it can take
advantage of an acidic milieu for
proton-dependent transport.
There are two transmembrane
transporter systems now known to be
involved in cellular folate uptake—a
reduced folate carrier, described pre-
viously, and the newly identified high-
affinity folate transporter, PCFT. In ad-
dition,GPI-linked folate receptors have
also been identified, which can medi-
ate cellular folate uptake by endocyto-7 Elsevier Inc.sis (Birn, 2006). The fate of
receptor-internalized folate
has not been worked out,
but this situation is reminis-
cent of the concentrating
role of the transferrin recep-
tor in the internalization of
iron-loaded transferrin (re-
viewed in Hentze et al.,
2004). In the transferrin cy-
cle, endosomal acidification
allows for transfer of iron to
the cytoplasm by DMT1. If,
like DMT1, PCFT is also ex-
pressed on the endosomal
membrane in developing
erythroid precursors, it may
mediate transfer of internal-
ized folates from the acidi-
fied endosome to the cyto-
plasm (Figure 1).
The identification of pa-
tients with mutations in
PCFT establishes the physi-
ological importance of this
new transporter. It will be
interesting to determine
whether hypomorphic vari-
ants of PCFT are associ-
ated with susceptibility to
folate deficiency or an in-creased incidence of neural tube birth
defects.
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